CD8A and neoplasm: Since p40 mAb upregulated human CD4+IFNγ+ and CD8+IFNγ+ T cells in the spleen of PDX mice, next we investigated whether p40 mAb treatment was capable of mounting these immune responses in vivo in tumor tissues.